I
L-6 and IFN-␥ activate essential Janus kinases͞signal transducers and activators of transcription (JAKs͞STATs) and additional signals through distinct type I and type II cytokine receptors (reviewed in refs. [1] [2] [3] . For IL-6, signaling occurs through dimerization of the common gp130 signal transduction subunit of the IL-6 family of cytokine receptors. In response to ligand, JAK1, JAK2, Tyk2, STAT1, and STAT3 are all activated; the JAKs are activated through the conserved membraneproximal binding domain, and the STATs are activated through four more distal receptor tyrosine motifs (2) (3) (4) . JAK1 and STAT3 play major roles in the response (4, 5) . For IFN-␥, signaling occurs through the IFN-␥ receptor subunits 1 and 2 (IFNGR1 and -2) and characteristically triggers prolonged STAT1 activation. The internal membrane proximal JAK1-and JAK2-binding domains of IFNGR1 and -2 and the distal Y440 STAT1 recruitment motif of IFNGR1 are essential for activity (reviewed in ref. 6) . In experiments to determine the interchangeability of signaling components, minimal chimeric receptors comprising the external domain of the erythropoietin (Epo) receptor and the transmembrane, JAK-binding domain and Y905 motif of the gp130 signal transduction receptor subunit of the IL-6 receptor, were shown to mediate an IFN-␥-like response in both wild-type and IFN-␥ receptor Ϫ cells (7) . In parallel, STAT3 Ϫ mouse embryo fibroblasts (MEFs) were developed to examine the role of STAT3 in signaling in response to different cytokines (8) . The observation of prolonged STAT1 activation and the induction of STAT1-dependent genes by IL-6 in the absence of STAT3 (S.T. and B.S., unpublished work) prompted a more detailed comparison with the IFN-␥ response. Here, we show that in the absence of STAT3, an IFN-␥-like response to IL-6 is observed.
Materials and Methods
Cell Lines and Culture. STAT3 floxed͞floxed (wild-type) MEFs were derived from individual 14-day-old STAT3 floxed͞floxed embryos and grown in DMEM supplemented with 10% (vol͞vol) heat-inactivated FCS͞2 mM L-glutamine͞50 units͞ml penicillin͞50 g͞ml streptomycin (GIBCO͞BRL) and immortalized according to Todaro and Green (9) . For the STAT3 Ϫ (deleted͞ deleted, ⌬͞⌬) MEFs, to delete the floxed STAT3 alleles, the floxed͞floxed MEFs were infected with a recombinant adenovirus expressing the Cre recombinase (10) . Individual clones were isolated from the infected pool by limiting dilution and were genotyped by PCR (8) . Genotypes were confirmed by Southern and Western blot analyses (8) . For complemented cells, the STAT3 Ϫ MEFs were stably transfected with pZeo-STAT3 and selected with zeocin (400 g͞ml, Invitrogen). Individual clones, isolated by limiting dilution, were characterized for comparable STAT3 expression to wild-type MEFs.
Antibodies and Cytokines. Antibodies against STAT1 and STAT3 were obtained from Santa Cruz Biotechnology; phycoerythrin (PE)-conjugated anti-mouse-I-A͞I-E antibody, the neutralizing antibody against IFN-␥, and the isotypic control antibody were obtained from PharMingen. Phosphorylated tyrosine residues were detected by using a mix of PY-20 (Transduction Laboratories, Lexington, KY) and 4G10 (Upstate Biotechnology, Lake Placid, NY) antibodies. Human IL-6 and soluble IL-6 receptor were obtained from R & D Systems. Highly purified, recombinant murine IFN-␥ (1-2 ϫ 10 7 units͞mg) was the generous gift of G. Adolf (Ernst-Boehringer Institut für Arzneimittelforschung, Vienna, Austria).
Cell Lysis, Immunoprecipitations, Western Blotting, and Electrophoretic Mobility-Shift Assays (EMSAs). Cell lysis was performed on ice in 50 mM Tris, pH 8.0͞0.5% (vol͞vol) Nonidet P-40͞ 10% (vol͞vol) glycerol͞150 mM NaCl͞1 mM DTT͞0.1 mM EDTA͞0.2 mM sodium orthovanadate͞25 mM sodium f luoride͞0.5 mM phenylmethylsulfonyl f luoride͞3 g͞ml aprotinin͞1 g͞ml leupeptin. Cell debris was removed by centrifugation and whole-cell extracts used for EMSA or immunoprecipitations, as described (11 the arrays were carried out as described (7, 12) . Detailed protocols are available from the Kerr lab on request. Fig. 1) . In contrast, in the STAT3 Ϫ MEFs (⌬͞⌬), the activation of STAT1 shows similarly prolonged kinetics in response to either ligand (Fig. 1) . It is reasonable to conclude that in wild-type cells there is a STAT3-dependent down-regulation of STAT1 activity. It will be of interest to determine whether this down-regulation is direct or indirect (14) and what are the mechanisms involved. There is no corresponding difference in the extent or kinetics of JAK activation in response to IL-6 in the wild-type vs. the STAT3 Ϫ cells (data not presented). The inhibition of STAT1 function(s) is unlikely to reflect simple competition between STAT1 and -3 either at or downstream of the receptor; for example, in wild-type cells, STAT3 activation by IL-6 or OSM does not inhibit an IFN-␥-mediated response. Intriguingly, the STAT1 ''activated'' in response to IL-6 or OSM seems to be defective in mediating a transcriptional response (ref. 15 , and H.I., B.S., A.P.C.-P., and I.M.K., unpublished work). The data are in accord with at least two mechanisms for the inhibition: the first governs the transcriptional activity of the ''activated'' STAT1, and the second governs the kinetics of the activation͞deactivation. A role(s) for STAT1͞3 heterodimers in either or both of these cannot, of course, be excluded.
Induction of IFN-Inducible Genes by IL-6 in the Absence of STAT3.
Consistent with the prolonged STAT1 activation, IL-6 efficiently induces the expression of IFN-␥-inducible genes in STAT3 Ϫ but not in wild-type MEFs. Wild-type and STAT3 Ϫ MEFs were stimulated for 3, 6, and 18 h with physiological concentrations of IFN-␥ or IL-6 and were subjected to expression profiling by using low-density cDNA arrays representing a selection of predominantly IFN-␥-inducible genes. The 30 most highly IFN-␥-induced genes at 6 and 18 h are listed (Table 1 ). In wild-type cells, none of these genes was induced in response to IL-6. In contrast, in the STAT3 Ϫ cells, the same spectrum of genes was induced with similar kinetics in response to the two ligands: of the roughly 70 genes represented on the arrays, all of those induced by IFN-␥ also were induced by IL-6 (Table 1) 
cells failed to induce an antiviral response (data not presented).
It is reasonable to conclude that the induction of the IFN-␥-like response through IL-6 does not reflect the secondary production of either type I or type II IFNs.
Induction of Class II MHC Antigens and an Antiviral State by IL-6 in the
Absence of STAT3. The induction of an antiviral state is characteristic of the IFNs, and the induction of class II MHC antigens is characteristic of IFN-␥ in particular. Therefore, the ability of IL-6 to induce such responses in the STAT3 Ϫ cells was investigated. Cell-surface expression of class II MHC antigens was observed with time in the wild-type MEFs in response to IFN-␥ but not IL-6 (data for the 72-h time points only are presented in Fig. 2 ). In the absence of STAT3, comparable levels of expression were observed for IFN-␥ and IL-6 (Fig. 2) . Similarly, the treatment of wild-type cells with IFN-␥, but not IL-6, provided good protection vs. the cytopathic effects of EMC virus infection (stained cells, Fig. 3 Lower, 'C' rows). In cells lacking STAT3, substantial protection was observed with both ligands (Fig. 3 Upper). In both types of cell, as expected, protection vs. the cytopathic effects of EMC virus through IFN-␥ was inhibited by neutralizing antibody to IFN-␥ (Fig. 3 Upper and Lower, IFN-␥ rows). No such effect of the antibody was observed on the protection provided by IL-6, again excluding any role for IFN-␥ in the IL-6 response in the STAT3 Ϫ cells (Fig. 3 Upper, compare the IFN-␥ rows with the IL-6 rows). When stably complemented with STAT3, the STAT3 Ϫ MEFs (⌬͞⌬) show in each of these Comparative induction of IFN-␥-inducible genes in wild-type (fl͞fl) and STAT3 Ϫ (⌬͞⌬) MEFs in response to IFN-␥ and IL-6. STAT3 fl͞fl and STAT3 ⌬͞⌬ MEFs were treated with 200 ng͞ml IL-6 and 250 ng͞ml sIL-6R or 1,000 units͞ml IFN-␥ for the times indicated. RNA isolation, labeling of 33 P-cDNA and macroarray analysis were as described (7, 12) . Data are representative of at least three experiments. 
Discussion
Activated STAT1 diffuses freely, consistent with random-walk models for movement in both the cytoplasmic and nuclear compartments of the cell (11) , and a minimal, completely foreign, chimeric receptor can mediate an IFN-␥-like response (7), data indicative of highly flexible modular signaling. Consistent with this finding, it is shown here that, in the absence of STAT3, an IFN-␥-like response is mediated through the endogenous IL-6 receptor. A priori, this IFN-␥-like response could occur through cross-recruitment or -phosphorylation of IFNGR1. Rigorous exclusion of any such possibility would, of course, require cells doubly negative for STAT3 and IFNGR1. In the work with the chimeric receptors, however, cross-phosphorylation of IFNGR1, although observed in wild-type cells, was not required for the IFN-␥-like response, which was equally potent in IFNGR1 Ϫ cells (7) . Thus, tempting though it might be to invoke a requirement for receptor cross-phosphorylation, it is unlikely to be the case. It is more likely, therefore, that the IFN-␥-like response to IL-6 reflects a high degree of overlap in the signals generated through the IFN-␥ and IL-6 receptors per se. IL-6 and IFN-␥ are known to activate multiple common pathways in addition to the STATs, including those for Ser-727 phosphorylation of STAT1 (16, 17) and the phosphatidylinositol 3-kinase͞Akt, MKK1͞ERK1 and -2, and p38 mitogenactivated protein kinase pathways (18-20, reviewed in ref. 21 ), all of which are, in fact, activated by both ligands in both the wild-type and STAT3 Ϫ MEFs (data not presented). Consistent with this finding, the activation of STAT1 is essential but not sufficient, for example, for a full IFN-␥ antiviral response (22, 23) . Accordingly, it is likely that, in the absence of STAT3, the prolonged activation of STAT1 is essential but not sufficient for the IFN-␥-like response to IL-6. All of the pathways necessary for the latter response must, however, be activated through the highly disparate IFN-␥ and IL-6 receptors in the STAT3 Ϫ cells, which, in turn, is in accord with the concept of a generic or ''core'' set of signals from JAK͞receptor complexes with add-on modulation through additional receptor elements. These are combined, presumably, with cell-type specific modulation through variation in cellular background. Core signaling is also suggested by the high degree of overlap in the responses to different growth factors revealed by microarray expression profiling (21, (23) (24) (25) . It is particularly intriguing that analogous core signaling has been proposed by Ihle and coworkers (26) from an analysis of the responses observed through modified Epo receptors in a variety of transgenic mice. Irrespective of mechanism, however, the data here are of interest per se and confirm the recognized potential for complexity in the interpretation of phenotypes observed in mutants in signaling pathways in knockout mice. Accepting the fundamental role of STAT3 in multiple pathways and that these data are likely only a particular example of what may well prove to be a more general phenomenon, they also emphasize the caution necessary in the proposed use of signaling inhibitors, including those for STAT3, in the clinical treatment of patients (27, 28) .
We thank Frank Graham for the adenovirus vector expressing the Cre recombinase and Gunter Adolf and Howard Young for generous gifts of highly purified, recombinant murine IFN-␥ and an RNase protection probe for murine IFN-␥, respectively. We also thank Sandra Diebold, Roman Sporri, Oliver Schulz, and Caetano 
